Skip to main content

Regulatory & Access Resources

Browse our regulatory & access resources to find the latest articles, blogs, brochures, and videos from our experts. See the latest content below.

Inclusion for all: Expanding trial accessibility for transgender and nonbinary patients

Drug developers and the clinical research community are working to increase diversity, equity, inclusion and belonging within clinical trials. By recruiting diverse patient populations, study results are more reflective of real-world patient populations and widen access to care. As a start, our industry has predominantly focused on racial and ethnic DEI. That’s critical work, but diversity extends beyond that into other areas too, such as gender identity, disability and socioeconomic status.